PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
7492771-5	1995	Furthermore, sodium salicylate blocked the LPS-induced proteolytic degradation of I kappa B alpha, which prevented the nuclear translocation of c-Rel/p65 heterodimers.	Sodium Salicylate	13-30	RELA proto-oncogene, NF-kB subunit	Homo sapiens	150-153	
8621937-5	1996	We found that sodium salicylate inhibited activation of NF-kappa B (p50/p65 and p65/p65) by preventing phosphorylation and subsequent degradation of the inhibitor 1 kappa B-alpha.	Sodium Salicylate	14-31	RELA proto-oncogene, NF-kB subunit	Homo sapiens	72-75	
8621937-5	1996	We found that sodium salicylate inhibited activation of NF-kappa B (p50/p65 and p65/p65) by preventing phosphorylation and subsequent degradation of the inhibitor 1 kappa B-alpha.	Sodium Salicylate	14-31	RELA proto-oncogene, NF-kB subunit	Homo sapiens	80-83	
8621937-5	1996	We found that sodium salicylate inhibited activation of NF-kappa B (p50/p65 and p65/p65) by preventing phosphorylation and subsequent degradation of the inhibitor 1 kappa B-alpha.	Sodium Salicylate	14-31	RELA proto-oncogene, NF-kB subunit	Homo sapiens	80-83	
9467376-0	1996	Inhibition of nuclear factor kappa B subunit p65 mRNA accumulation in lipopolysaccharide-stimulated human monocytic cells treated with sodium salicylate.	Sodium Salicylate	135-152	RELA proto-oncogene, NF-kB subunit	Homo sapiens	45-48	
9467376-8	1996	High doses of sodium salicylate suppressed NF-kappa B p65 mRNA accumulation, resulting in suppression of total NF-kappa B, p50 on tissue oligonucleotide had no effects on lipopolysaccharide-induced NF-kappa B activation.	Sodium Salicylate	14-31	RELA proto-oncogene, NF-kB subunit	Homo sapiens	54-57